3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
48
Lung Neoplasms
24
Carcinoma, Hepatocellular
24
Small Cell Lung Carcinoma
16
Urinary Bladder Neoplasms
12
Cholangiocarcinoma
12
Breast Neoplasms
10
Biliary Tract Neoplasms
10
Neoplasms
9
Neoplasm Metastasis
9
Liver Neoplasms
9
Pancreatic Neoplasms
7
Carcinoma
6
Endometrial Neoplasms
5
Colorectal Neoplasms
5
Triple Negative Breast Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Neoplasms by Site
4
Gallbladder Neoplasms
4
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Respiratory Tract Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Bile Duct Neoplasms
3
Adenocarcinoma
3
Thyroid Neoplasms
2
Thoracic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Interventions
Cyclophosphamide
18
fludarabine phosphate
12
pembrolizumab
11
Nivolumab
11
Brentuximab Vedotin
11
Mycophenolic Acid
10
Doxorubicin
10
fludarabine
9
Dacarbazine
9
Whole-Body Irradiation
8
Etoposide
8
Vinblastine
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Filgrastim
7
Cyclosporine
7
Granulocyte Colony-Stimulating Factor
6
Sirolimus
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Gemcitabine
5
Busulfan
5
Tacrolimus
4
pegfilgrastim
3
Vinorelbine
3
Stem Cell Transplantation
3
Rituximab
3
Radiation
3
Prednisone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
durvalumab
×
90 days
×
Clear all
No trials found.